<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="4-part\PMC7296089\results\search\disease\results.xml">
  <result pre="the Research Topic Respiratory Virus Infection: Recent Advances respiratory virus" exact="influenza" post="epidemiology pathogenesis therapeutics vaccines fig-count: table-count: equation-count: ref-count: page-count:"/>
  <result pre="human pathogens with epidemic or pandemic potential. Such viruses include" exact="avian influenza" post="viruses and the Middle East Respiratory Syndrome (MERS) and"/>
  <result pre="pathogens with epidemic or pandemic potential. Such viruses include avian" exact="influenza" post="viruses and the Middle East Respiratory Syndrome (MERS) and"/>
  <result pre="RSV and one each on rhinovirus and MERS coronavirus. Seasonal" exact="influenza" post="A and B virus epidemics globally cause up to"/>
  <result pre="permanent threat of pandemics. Vaccines and specific antiviral drugs against" exact="influenza" post="are available but they have limitations including variable vaccine"/>
  <result pre="al. review the current knowledge on the structure of the" exact="influenza" post="virus neuraminidase and link the structural features of this"/>
  <result pre="Guo et al. studied the genetic changes that occur in" exact="avian influenza" post="A H5 viruses when they infect humans. Identification of"/>
  <result pre="et al. studied the genetic changes that occur in avian" exact="influenza" post="A H5 viruses when they infect humans. Identification of"/>
  <result pre="humans is needed for evaluating the pandemic risk related to" exact="avian influenza" post="viruses. National reporting of clinical microbiology results is an"/>
  <result pre="is needed for evaluating the pandemic risk related to avian" exact="influenza" post="viruses. National reporting of clinical microbiology results is an"/>
  <result pre="et al. studied the effects of such laboratory merging on" exact="influenza" post="surveillance in Belgium. They report benefits of the integration"/>
  <result pre="report benefits of the integration of whole genome sequencing of" exact="influenza" post="viruses performed in centralized clinical microbiology laboratories into the"/>
  <result pre="inhibitors are widely used for treatment (and sometimes prevention) of" exact="influenza" post="infection, and they have demonstrated efficacy. However, new drugs"/>
  <result pre="scenario of developing antiviral resistance. Several new antiviral drugs against" exact="influenza" post="have been developed or are under development, including polymerase"/>
  <result pre="are the cornerstone in protection against influenza. However, currently used" exact="influenza" post="vaccines have limitations and the process of production in"/>
  <result pre="not only against H1N1pdm09 virus but also against avian H5N1" exact="influenza" post="virus. RSV occurs in yearly epidemics that cause high"/>
 </snippets>
</snippetsTree>
